Dr. Ronald Shinn, Ph. D.
Partner, Chairman, President and CEO
Career Objectives:
Develop and fund programs improving the quality of life throughout the world. To pioneer the development and leadership of a pharmaceutical company, such as ArTec, Inc., through the use of Tubercin that will successfully impact life threatening diseases such as Cancer.
Professional Experiences:
From 1989 to 2004, a span of fifteen years, Dr. Ronald Shinn has been involved in investment related companies such as Shinn Capital Group Inc., and Dr. Ronald Shinn and Associates. As an Entrepreneur, Dr. Shinn has participated in various financial projects in different parts of the world, including the United States. It has been the underlying theme in Dr. Shinn's involvement that profits in business enterprises be designated for humanitarian purposes as well as accomplishing the goals of free enterprise business pursuits.
Medical Research and Funding has become priorities for Dr. Ronald Shinn in the last four years especially when it involves the introduction of Tubercin in combating Cancer.
Education and Achievements:
Dr. Shinn received in 1969 the Ph. D. Degree in Education from the University of California at Berkley. In his course of studies were numerous courses in Research and Higher Education. In later years, he was Chief of Research for the California Department of Corrections and was appointed by then Governor Ronald Reagan to the Board of Directors of the Far West Laboratories. Dr. Shinn has been listed in Personalities of the West and Midwest as well as in Community Leaders and Noteworthy Americans. In addition, at the University level he has published articles and books.
Market Data 
Markets 
AI
